IL6 and inflammatory bowel disease: The data provide novel insights into the molecular mechanisms of IBD, and alterations in the miR‐223/IL‐6/STAT3 signaling pathway may be involved in the inflammatory response and contribute to the pathogenesis of chronic inflammatory disease.